open access

Vol 21, No 6 (2016)
Original research articles
Published online: 2016-11-01
Submitted: 2016-02-25
Get Citation

Dosimetric feasibility of an “off-breast isocenter” technique for whole-breast cancer radiotherapy

Juan-Francisco Calvo-Ortega, Sandra Moragues, Miquel Pozo, Joan Casals
DOI: 10.1016/j.rpor.2016.06.001
·
Rep Pract Oncol Radiother 2016;21(6):500-507.

open access

Vol 21, No 6 (2016)
Original research articles
Published online: 2016-11-01
Submitted: 2016-02-25

Abstract

Aim

To investigate the viability of placing the treatment isocenter at the patient midline for breast cancer radiotherapy in order to avoid the risk of collisions during image-guided setup and treatment delivery.

Background

The use of kilovoltage orthogonal setup images has spread in last years in breast radiotherapy. There is a potential risk of an imaging system–patient collision when the isocenter is laterally placed.

Materials and methods

Twenty IMRT plans designed by placing the isocenter within the breast volume (“plan_ref”), were retrospectively replanned by shifting the isocenter at the patient's midline (“plan_off-breast”). An integrated simultaneous boost (SIB) technique was used. Multiple metrics for the planning target volumes (PTVs) and organs at risk (OARs) were compared for both approaches using a paired t test.

Results

Comparing plan_ref vs. plan_off-breast, no significant differences in PTV coverage (V95%) were found (96.5% vs. 96.2%; p[[ce:hsp sp="0.25"/]]=[[ce:hsp sp="0.25"/]]0.361 to PTVbreast; 97.0% vs. 97.0%; p[[ce:hsp sp="0.25"/]]=[[ce:hsp sp="0.25"/]]0.977 to PTVtumor_bed). With regard to OARs, no substantial differences were observed in any analyzed metric: V5Gy (30.3% vs. 31.4%; p[[ce:hsp sp="0.25"/]]=[[ce:hsp sp="0.25"/]]0.486), V20Gy (10.3% vs. 10.3%; p[[ce:hsp sp="0.25"/]]=[[ce:hsp sp="0.25"/]]0.903) and mean dose (7.1[[ce:hsp sp="0.25"/]]Gy vs. 7.1[[ce:hsp sp="0.25"/]]Gy; p[[ce:hsp sp="0.25"/]]=[[ce:hsp sp="0.25"/]]0.924) to the ipsilateral lung; V5Gy (11.2% vs. 10.0%; p[[ce:hsp sp="0.25"/]]=[[ce:hsp sp="0.25"/]]0.459), V30Gy (0.7% vs. 0.6%; p[[ce:hsp sp="0.25"/]]=[[ce:hsp sp="0.25"/]]0.251) and mean dose (2.3[[ce:hsp sp="0.25"/]]Gy vs. 2.2[[ce:hsp sp="0.25"/]]Gy; p[[ce:hsp sp="0.25"/]]=[[ce:hsp sp="0.25"/]]0.400) to the heart; and average dose to the contralateral breast (0.4[[ce:hsp sp="0.25"/]]Gy vs. 0.5[[ce:hsp sp="0.25"/]]Gy; p[[ce:hsp sp="0.25"/]]=[[ce:hsp sp="0.25"/]]0.107).

Conclusions

The off-breast isocenter solution resulted in dosimetrically comparable plans as the reference technique, avoiding the collision risk during the treatment session.

Abstract

Aim

To investigate the viability of placing the treatment isocenter at the patient midline for breast cancer radiotherapy in order to avoid the risk of collisions during image-guided setup and treatment delivery.

Background

The use of kilovoltage orthogonal setup images has spread in last years in breast radiotherapy. There is a potential risk of an imaging system–patient collision when the isocenter is laterally placed.

Materials and methods

Twenty IMRT plans designed by placing the isocenter within the breast volume (“plan_ref”), were retrospectively replanned by shifting the isocenter at the patient's midline (“plan_off-breast”). An integrated simultaneous boost (SIB) technique was used. Multiple metrics for the planning target volumes (PTVs) and organs at risk (OARs) were compared for both approaches using a paired t test.

Results

Comparing plan_ref vs. plan_off-breast, no significant differences in PTV coverage (V95%) were found (96.5% vs. 96.2%; p[[ce:hsp sp="0.25"/]]=[[ce:hsp sp="0.25"/]]0.361 to PTVbreast; 97.0% vs. 97.0%; p[[ce:hsp sp="0.25"/]]=[[ce:hsp sp="0.25"/]]0.977 to PTVtumor_bed). With regard to OARs, no substantial differences were observed in any analyzed metric: V5Gy (30.3% vs. 31.4%; p[[ce:hsp sp="0.25"/]]=[[ce:hsp sp="0.25"/]]0.486), V20Gy (10.3% vs. 10.3%; p[[ce:hsp sp="0.25"/]]=[[ce:hsp sp="0.25"/]]0.903) and mean dose (7.1[[ce:hsp sp="0.25"/]]Gy vs. 7.1[[ce:hsp sp="0.25"/]]Gy; p[[ce:hsp sp="0.25"/]]=[[ce:hsp sp="0.25"/]]0.924) to the ipsilateral lung; V5Gy (11.2% vs. 10.0%; p[[ce:hsp sp="0.25"/]]=[[ce:hsp sp="0.25"/]]0.459), V30Gy (0.7% vs. 0.6%; p[[ce:hsp sp="0.25"/]]=[[ce:hsp sp="0.25"/]]0.251) and mean dose (2.3[[ce:hsp sp="0.25"/]]Gy vs. 2.2[[ce:hsp sp="0.25"/]]Gy; p[[ce:hsp sp="0.25"/]]=[[ce:hsp sp="0.25"/]]0.400) to the heart; and average dose to the contralateral breast (0.4[[ce:hsp sp="0.25"/]]Gy vs. 0.5[[ce:hsp sp="0.25"/]]Gy; p[[ce:hsp sp="0.25"/]]=[[ce:hsp sp="0.25"/]]0.107).

Conclusions

The off-breast isocenter solution resulted in dosimetrically comparable plans as the reference technique, avoiding the collision risk during the treatment session.

Get Citation

Keywords

Off-breast; Isocenter; Collision; IMRT; SIB

About this article
Title

Dosimetric feasibility of an “off-breast isocenter” technique for whole-breast cancer radiotherapy

Journal

Reports of Practical Oncology and Radiotherapy

Issue

Vol 21, No 6 (2016)

Pages

500-507

Published online

2016-11-01

DOI

10.1016/j.rpor.2016.06.001

Bibliographic record

Rep Pract Oncol Radiother 2016;21(6):500-507.

Keywords

Off-breast
Isocenter
Collision
IMRT
SIB

Authors

Juan-Francisco Calvo-Ortega
Sandra Moragues
Miquel Pozo
Joan Casals

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk, Poland
tel.:+48 58 320 94 94, fax:+48 58 320 94 60, e-mail: journals@viamedica.pl